Showing results (521-530 of 575) with videos related to

Sort By:
Pageof 58
Life Science Alliance|November 21, 2018
CARM1 methylates MED12 to regulate its RNA-binding abilityDonghang Cheng, Vidyasiri Vemulapalli, Yue Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2021
Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALLNirali N Shah, Daniel W Lee, Bonnie Yates, et al.
Blood Advances|October 7, 2021
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 daysLekha Mikkilineni, Bonnie Yates, Seth M Steinberg, et al.
Transplantation and Cellular Therapy|July 2, 2023
Chimeric Antigen Receptor T Cells as Salvage Therapy for Post-Chimeric Antigen Receptor T Cell FailureElizabeth M Holland, Bonnie Yates, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2019
Modulation of Target Antigen Density Improves CAR T-cell Functionality and PersistenceSneha Ramakrishna, Steven L Highfill, Zachary Walsh, et al.
Molecular Cell|April 22, 2020
MYC Controls the Epstein-Barr Virus Lytic SwitchRui Guo, Chang Jiang, Yuchen Zhang, et al.
The Journal of Infectious Diseases|May 28, 2014
Sevelamer does not decrease lipopolysaccharide or soluble CD14 levels but decreases soluble tissue factor, low-density lipoprotein (LDL) cholesterol, and oxidized LDL cholesterol levels in individuals with untreated HIV infectionNetanya G Sandler, Xinyan Zhang, Ronald J Bosch, et al.
Nature Medicine|May 5, 2015
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptorsAdrienne H Long, Waleed M Haso, Jack F Shern, et al.
Journal for Immunotherapy of Cancer|May 9, 2022
Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulationElizabeth M Holland, John C Molina, Kniya Dede, et al.
Journal of Virology|November 16, 2012
Loss of a tyrosine-dependent trafficking motif in the simian immunodeficiency virus envelope cytoplasmic tail spares mucosal CD4 cells but does not prevent disease progressionMatthew W Breed, Andrea P O Jordan, Pyone P Aye, et al.
Pageof 58